Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Zenz

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Pain and Symptom Management|April 1, 1995
Severe undertreatment of cancer pain: a 3-year survey of the German situationM Zenz, T Zenz, M Tryba, et al.
Nucleic Acids Research|March 10, 2001
Molecular cloning of Ian4: a BCR/ABL-induced gene that encodes an outer membrane mitochondrial protein with GTP-binding activityL Dahéron, T Zenz, L D Siracusa, et al.
Liver|February 13, 2001
Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS)T Zenz, M Rössle, H Bertz, et al.
Leukemia|May 16, 2008
How little is too much? p53 inactivation: from laboratory cutoff to biological basis of chemotherapy resistanceT Zenz, S Häbe, T Denzel, et al.
British Journal of Haematology|April 16, 2008
Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutationsT Zenz, K Döhner, T Denzel, et al.
Genes and Immunity|January 16, 2004
hIan5: the human ortholog to the rat Ian4/Iddm1/lyp is a new member of the Ian family that is overexpressed in B-cell lymphoid malignanciesT Zenz, A Roessner, A Thomas, et al.
Current Hematologic Malignancy Reports|November 29, 2012
What do we do with chronic lymphocytic leukemia with 17p deletion?L Sellner, S Denzinger, S Dietrich, et al.
Leukemia|November 28, 2013
Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeletonP B Knudsen, B Hanna, S Ohl, et al.
Leukemia|January 19, 2011
Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral bloodN Bhattacharya, S Diener, I S Idler, et al.
Scientific Reports|August 15, 2018
Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphomaK Tomska, R Kurilov, K S Lee, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Pain and Symptom Management|April 1, 1995
Severe undertreatment of cancer pain: a 3-year survey of the German situationM Zenz, T Zenz, M Tryba, et al.
Nucleic Acids Research|March 10, 2001
Molecular cloning of Ian4: a BCR/ABL-induced gene that encodes an outer membrane mitochondrial protein with GTP-binding activityL Dahéron, T Zenz, L D Siracusa, et al.
Liver|February 13, 2001
Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS)T Zenz, M Rössle, H Bertz, et al.
Leukemia|May 16, 2008
How little is too much? p53 inactivation: from laboratory cutoff to biological basis of chemotherapy resistanceT Zenz, S Häbe, T Denzel, et al.
British Journal of Haematology|April 16, 2008
Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutationsT Zenz, K Döhner, T Denzel, et al.
Genes and Immunity|January 16, 2004
hIan5: the human ortholog to the rat Ian4/Iddm1/lyp is a new member of the Ian family that is overexpressed in B-cell lymphoid malignanciesT Zenz, A Roessner, A Thomas, et al.
Current Hematologic Malignancy Reports|November 29, 2012
What do we do with chronic lymphocytic leukemia with 17p deletion?L Sellner, S Denzinger, S Dietrich, et al.
Leukemia|November 28, 2013
Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeletonP B Knudsen, B Hanna, S Ohl, et al.
Leukemia|January 19, 2011
Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral bloodN Bhattacharya, S Diener, I S Idler, et al.
Scientific Reports|August 15, 2018
Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphomaK Tomska, R Kurilov, K S Lee, et al.
Pageof 4